Syntopix to present TBHQ data at ICAAC 2010
18 June 2010
By Sarah Gregory
Syntopix has joined forces with the University of Leeds to conduct a research project into the antibacterial activity and mechanism of action of the lipophilic antioxidant tert-butylhydroquinone (TBHQ).
Working with Professor Ian Chopra, Dr Nicki Ooi, and Dr Alex O’Neill, the Research and Scientific Directors of Syntopix Dr Jon Cove and Dr Anne Eady are looking to investigate the compounds antimicrobial mode of action.
Research results will be published in a poster publication later this year at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy meeting which is taking place between the 12 Sept – 15 Sept 2010 in Boston, USA.
Syntopix has joined forces with the University of Leeds to conduct a research project into the antibacterial activity and mechanism of action of the lipophilic antioxidant tert-butylhydroquinone (TBHQ).
Working with Professor Ian Chopra, Dr Nicki Ooi, and Dr Alex O’Neill, the Research and Scientific Directors of Syntopix Dr Jon Cove and Dr Anne Eady are looking to investigate the compounds antimicrobial mode of action.
Research results will be published in a poster publication later this year at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy meeting which is taking place between the 12 Sept – 15 Sept 2010 in Boston, USA.